Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety of TAK-242 in Adults With Severe Sepsis

NCT00143611 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00143611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety of TAK-242 in Adults With Severe Sepsis
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
February 28, 2007
Enrollment
277 (actual)
Sites
144

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis